Glaukos Drug Patent Portfolio
Glaukos owns 2 orange book drugs protected by 9 US patents Given below is the list of Glaukos's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12201555 | Drug eluting ocular implant | 14 Feb, 2031 | Active |
| US10206813 | Implants with controlled drug delivery features and methods of using same | 17 Oct, 2030 | Active |
| US11426306 | Implants with controlled drug delivery features and methods of using same | 17 Oct, 2030 | Active |
| US12201557 | Drug eluting ocular implant and method of treating an ocular disorder | 18 Jun, 2030 | Active |
| US9649428 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 21 May, 2029 | Active |
| US7806265 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 01 Feb, 2029 | Active |
| US9539241 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 02 Jan, 2028 | Active |
| US8186511 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 19 Jul, 2026 | Active |
| US9205075 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 19 Jul, 2026 | Active |
Latest Legal Activities on Glaukos's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Glaukos.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 10 Jul, 2024 | US9539241 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 23 Oct, 2023 | US8186511 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 Jun, 2023 | US9205075 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 30 Aug, 2022 | US11426306 |
|
Recordation of Patent Grant Mailed
Critical
| 30 Aug, 2022 | US11426306 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 Aug, 2022 | US10206813 |
|
Email Notification
Critical
| 11 Aug, 2022 | US11426306 |
|
Issue Notification Mailed
Critical
| 10 Aug, 2022 | US11426306 |
| Dispatch to FDC | 29 Jul, 2022 | US11426306 |
| Workflow - Drawings Finished | 28 Jul, 2022 | US11426306 |
| Mail PUB other miscellaneous communication to applicant | 03 Jun, 2022 | US11426306 |
|
Email Notification
Critical
| 03 Jun, 2022 | US11426306 |
| PUB Other miscellaneous communication to applicant | 01 Jun, 2022 | US11426306 |
|
Application Is Considered Ready for Issue
Critical
| 06 May, 2022 | US11426306 |
| Dispatch to FDC | 06 May, 2022 | US11426306 |
Glaukos's Family Patents
Glaukos Drug List
Given below is the complete list of Glaukos's drugs and the patents protecting them.
1. Idose Tr
Idose Tr is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12201555 | Drug eluting ocular implant |
14 Feb, 2031
(5 years from now)
| Active |
| US10206813 | Implants with controlled drug delivery features and methods of using same |
17 Oct, 2030
(5 years from now)
| Active |
| US11426306 | Implants with controlled drug delivery features and methods of using same |
17 Oct, 2030
(5 years from now)
| Active |
| US12201557 | Drug eluting ocular implant and method of treating an ocular disorder |
18 Jun, 2030
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Idose Tr's drug page
2. Mitosol
Mitosol is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649428 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
21 May, 2029
(3 years from now)
| Active |
| US7806265 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
01 Feb, 2029
(3 years from now)
| Active |
| US9539241 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
02 Jan, 2028
(2 years from now)
| Active |
| US8186511 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
19 Jul, 2026
(9 months from now)
| Active |
| US9205075 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
19 Jul, 2026
(9 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mitosol's drug page